Broker Research
November 17, 2025 / 14:51 IST
Reported Consolidated quarterly numbers for Orchid Pharma are:Net Sales at Rs 193.52 crore in September 2025 down 13.1% from Rs. 222.70 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.72 crore in September 2025 down 121.01% from Rs. 27.24 crore in September 2024.
EBITDA stands at Rs. 9.30 crore in September 2025 down 75.44% from Rs. 37.86 crore in September 2024.
Orchid Pharma shares closed at 803.70 on November 13, 2025 (NSE) and has given 2.30% returns over the last 6 months and -44.20% over the last 12 months.
| Orchid Pharma | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 193.52 | 172.93 | 222.70 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 193.52 | 172.93 | 222.70 | | EXPENDITURE | | Consumption of Raw Materials | 112.27 | 110.16 | 153.72 | | Purchase of Traded Goods | 0.17 | 0.79 | -- | | Increase/Decrease in Stocks | 20.07 | -12.08 | -22.56 | | Power & Fuel | -- | -- | -- | | Employees Cost | 24.85 | 21.61 | 20.06 | | Depreciation | 8.90 | 8.65 | 8.63 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 37.64 | 38.28 | 41.14 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -10.38 | 5.52 | 21.71 | | Other Income | 10.77 | 11.45 | 7.52 | | P/L Before Int., Excpt. Items & Tax | 0.40 | 16.97 | 29.23 | | Interest | 3.73 | 3.26 | 3.33 | | P/L Before Exceptional Items & Tax | -3.33 | 13.71 | 25.90 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -3.33 | 13.71 | 25.90 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -3.33 | 13.71 | 25.90 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -3.33 | 13.71 | 25.90 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -2.39 | 1.20 | 1.34 | | Net P/L After M.I & Associates | -5.72 | 14.91 | 27.24 | | Equity Share Capital | 50.72 | 50.72 | 50.72 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.13 | 2.94 | 5.37 | | Diluted EPS | -1.13 | 2.94 | 5.37 | | EPS After Extra Ordinary | | Basic EPS | -1.13 | 2.94 | 5.37 | | Diluted EPS | -1.13 | 2.94 | 5.37 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
